Hannah Perpetua Victor

Hannah Perpetua Victor is an experienced professional in process development and biologics, currently serving as Sr. Scientist II in CMC Biologics Drug Substance Process Development at AbbVie since December 2017. Prior to this role, Hannah held various positions at Amgen, where responsibilities included senior associate roles in Drug Substance Technology Process Development and Clinical Immunology. Early career experience includes roles as a research assistant and intern at Albert Einstein College of Medicine and New York University. Hannah holds a Master of Science in Biotechnology from New York University and an Executive MBA in Business Administration from Quantic School of Business and Technology, in addition to a Bachelor of Technology in Bioinformatics from Sathyabama University.